Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meetings07-02-2023
07-02-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meeting06-02-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication regarding the dispatch of Postal Ballot Notice and e-voting information.05-02-2023
Gland Pharma Ltd - 543245 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice for seeking approval of the Members of the Company, to approve commission on profits as remuneration to Mr. Yiu Kwan Stanley Lau (DIN: 08455325), Independent Director04-02-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for registration of e-mail address of Members.03-02-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings call Transcript for Q3FY2331-01-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meeting31-01-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meeting27-01-2023
Buy Gland Pharma; target of Rs 1720: YES Securities
YES Securities is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 1720 in its research report dated January 23, 2023.25-01-2023